PATENT CLAIM ANALYSIS

Application Number: 16181628
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["424", "001650"]

Abstract:
Among the various aspects of the present disclosure is the provision of compositions and methods for imaging and treating subjects with amyloidosis or multiple myeloma with or without amyloidosis.

Claim (Index 14):
The method of  claim 9 , wherein\n \u03ba and \u03bb soluble free LC (sFLCs) concentrations are measured; a higher concentration, compared to a standard or control, of soluble free light chains (sFLCs) in the biological sample indicates that the subject has amyloidosis or renal failure; the subject is treated for MM with amyloidosis if FLCs concentration is higher than a standard or control; or the subject is treated for MM without amyloidosis if FLCs concentration is not higher than a standard or control.

Metadata:
- Claim Count in Document: 49.0
- Percentile: 98.0
- Lexical Diversity: 1.30435
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13314160', '15026545', '12811049', '15552614', '15258883']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7103055853054899
- 35 USC 102 Novelty (BERT): 0.4937995008669685
- Combined Prediction Score: 0.6886549768616378
- Mean Citation Score: 167.89954399999996
- Max Citation Score: 173.50372
- Similarity Product: 110.2842232571864

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test